Today: 13 June 2026
Hotel101 Global (HBNB) stock jumps 10% to $8.80 — what to watch before Monday
11 January 2026
1 min read

Hotel101 Global (HBNB) stock jumps 10% to $8.80 — what to watch before Monday

NEW YORK, January 11, 2026, 08:46 (EST) — Market closed.

  • Shares of Hotel101 Global Holdings Corp. ended Friday at $8.80, gaining 10% after reaching a peak of $8.90 during the session.
  • The move unfolded on light volume, leaving the stock vulnerable to sudden, headline-free swings.
  • Traders are focused on whether momentum holds Monday ahead of Tuesday’s U.S. CPI report.

Shares of Hotel101 Global Holdings Corp. jumped 10%, closing at $8.80 on Friday, up 80 cents from the previous close. The stock opened lower at $8.11, with roughly 32,600 shares changing hands.

The Nasdaq-listed stock climbed to the upper limit of its 52-week range, reaching $8.90 at its peak. Hotel101’s market cap now sits around $2.06 billion, a figure that, combined with the day’s trading volume, could amplify price fluctuations.

This is significant since Hotel101 is still a fresh listing in the U.S., and its stock can swing sharply when trading volume is low. The company, based in Singapore, functions as a subsidiary of Philippine real estate firm DoubleDragon, according to a recent filing.

Hotel101 made its Nasdaq debut via a merger with blank-check company JVSPAC Acquisition Corp, valuing the firm at an equity worth of $2.3 billion, Reuters reported. The move marked it as the first Philippine-owned firm to list on the exchange.

With limited analyst coverage, investors are relying heavily on ratings services and official filings for guidance. MarketBeat reported Saturday that Wall Street Zen slapped the stock with a “Sell” rating, while Weiss Ratings kicked off coverage also recommending a sell. MarketBeat

Hotel101 describes itself as an asset-light, proptech-focused hospitality platform. Simply put, it earns upfront revenue by selling standardized hotel units and then aims to collect recurring fees through managing and operating those units.

For now, the tape is calling the shots. The stock is testing recent highs, and even a small surge in buying sends it higher.

Thin liquidity works both ways. A dip in the first hour Monday wouldn’t require heavy selling to take hold, and smaller, newer listings often react swiftly to changes in risk appetite.

Investors are gearing up for a key U.S. data week that frequently shifts rate expectations in the stock market. On Tuesday at 8:30 a.m. ET, the Labor Department will publish the December consumer price index.

Stock Market Today

  • Ascletis Pharma Stock Falls 41.6% in a Month, Valuation Mixed Amid Losses
    June 13, 2026, 12:37 AM EDT. Ascletis Pharma (SEHK:1672) shares dropped 4.4% last week and 41.6% over the past month, raising questions about its valuation. The stock trades at a price-to-book (P/B) ratio of 4.7x, above the Hong Kong Biotech sector average of 3.2x but below a peer group average of 12.5x, signaling mixed valuation metrics. The company remains unprofitable with a negative return on equity of 18.61%, making earnings-based measures less relevant. While longer-term returns remain positive, recent revenue and net income weaknesses alongside ongoing losses pose risks. Investors are advised to review underlying data carefully before deciding on Ascletis Pharma's stock prospects amid a cautious market sentiment.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split
Previous Story

Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape
Next Story

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Go toTop